Skip to main content

GHRP-2 vs GHRP-6

Both GHRP-2 and GHRP-6 are used for growth-hormone. Here's how their evidence, dosing, and regulatory status actually compare.

GHRP-2

Evidence B

Growth Hormone Releasing Peptide 2

A potent synthetic ghrelin-mimetic GH secretagogue. Drives strong GH spikes but raises cortisol and prolactin more than newer alternatives like Ipamorelin.

View full GHRP-2 profile →

GHRP-6

Evidence B

Growth Hormone Releasing Peptide 6

An older GHS that produces strong appetite stimulation in addition to GH release. Largely supplanted by Ipamorelin and GHRP-2 for clinical use but still common in research stacks.

View full GHRP-6 profile →

Side-by-Side

AttributeGHRP-2GHRP-6
Evidence GradeBB
FDA StatusNot FDA-approved — research compound; previously studied as growth hormone deficiency diagnosticNot FDA-approved — research compound
Typical Dose100–300 mcg, 1–3 times daily (subcutaneous)100–300 mcg, 1–3 times daily (subcutaneous)
Clinics Indexed8664
Categoriesgrowth-hormone, anti-aginggrowth-hormone, appetite

Key reported benefits — GHRP-2

  • Strong GH release
  • Appetite stimulation
  • Muscle recovery

Key reported benefits — GHRP-6

  • GH release
  • Appetite stimulation
  • Cytoprotection

Educational use only

This comparison is for educational purposes and not medical advice. Peptide selection should be made with a licensed medical professional based on your individual goals, health history, and current evidence quality.

← Back to all comparisons